drugset / Trial / NCT02172794

Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)

NCT02172794

Phase 3 Completed 48 enrolled Boehringer Ingelheim
RandomizedCrossoverDouble-blindTreatment

Summary

The primary objective of this study is to evaluate the effect of tiotropium on gross muscular efficiency

Timeline

Start
2002-05
Primary completion
2005-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Salmeterol Other / unclassified Inhaled
Subject Tiotropium Other / unclassified 18 ug Inhaled